R. Thakker, Multiple endocrine neoplasia--syndromes of the twentieth century, J

R. Boni, A. Vortmeyer, S. Pack, W. Park, G. Burg et al., Somatic mutations of the MEN1 tumor suppressor gene detected in sporadic References 1 Advances in Breast Cancer: Pathways to Personalized Medicine, Clin Cancer Res, vol.14, pp.7988-99, 2008.

S. Rehm, J. Russo, F. Tavassoli, L. Wakefield, J. Ward et al., The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting, Oncogene, vol.19, pp.968-88, 2000.

R. Thakker, Multiple endocrine neoplasia--syndromes of the twentieth century, J

M. Hofmann, T. Schilling, P. Heilmann, O. Haisken, C. Wuster et al., Multiple endocrine neoplasia type 1 associated with multiple lipomas, Medizinische Klinik, vol.35, issue.Suppl. 2, pp.546-555, 1998.
DOI : 10.1007/BF03042664

R. Boni, A. Vortmeyer, S. Pack, W. Park, G. Burg et al., Somatic Mutations of the MEN1 Tumor Suppressor Gene Detected in Sporadic Angiofibromas, Journal of Investigative Dermatology, vol.111, issue.3, pp.539-579, 1998.
DOI : 10.1046/j.1523-1747.1998.00317.x

Y. Yang and X. Hua, In search of tumor suppressing functions of menin, Molecular and Cellular Endocrinology, vol.265, issue.266, pp.265-26634, 2007.
DOI : 10.1016/j.mce.2006.12.032

G. Chen, A. J. Wang, M. Farley, S. Lee, L. Lee et al., Menin Promotes the Wnt Signaling Pathway in Pancreatic Endocrine Cells, Molecular Cancer Research, vol.6, pp.1894-907, 2008.
DOI : 10.1158/1541-7786.MCR-07-2206

Y. Cao, R. Liu, X. Jiang, J. Lu, J. Jiang et al., Nuclear-cytoplasmic shuttling of menin regulates nuclear translocation of {beta}-catenin, Mol. Cell. Biol, pp.335-344, 2009.

M. Cleary, Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression, Mol Cell Biol, vol.24, pp.5639-5688, 2004.

T. Milne, C. Hughes, R. Lloyd, Z. Yang, O. Rozenblatt-rosen et al., Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors, Proceedings of the National Academy of Sciences, vol.102, issue.3, pp.749-54, 2005.
DOI : 10.1073/pnas.0408836102

K. Dreijerink, R. Varier, O. Van-beekum, E. Jeninga, J. Hoppener et al., The Multiple Endocrine Neoplasia type 1

K. Lorang, D. Libutti, S. Chandrasekharappa, S. Marx, S. Spiegel et al., A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors

P. Bertolino, W. Tong, D. Galendo, Z. Wang, and C. Zhang, Mutant Mice Develop a Range of Endocrine Tumors Mimicking Multiple Endocrine Neoplasia Type 1, Molecular Endocrinology, vol.17, issue.9, pp.1880-92, 2003.
DOI : 10.1210/me.2003-0154

P. Bertolino, W. Tong, P. Herrera, H. Casse, C. Zhang et al., Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice, Cancer Res, vol.63, pp.4836-4877, 2003.

P. Furth and L. Hennighausen, Cre-mediated gene deletion in the mammary gland, Nucleic Acids Research, vol.25, pp.4323-4353, 1997.

G. and H. Nk, Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues, Mol Cell Biol, vol.24, pp.3125-3156, 2004.

L. Arendt and L. Schuler, Transgenic Models to Study Actions of Prolactin

S. Tan and M. Nevalainen, Signal transducer and activator of transcription 5A/B in prostate and breast cancers, Endocrine Related Cancer, vol.15, issue.2, pp.367-90, 2008.
DOI : 10.1677/ERC-08-0013

J. Beijnum, A. Griffioen, J. Vink, P. Krimpenfort, J. Peterse et al., Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis, Cancer Cell, vol.10, pp.437-486, 2006.

D. Seldin, E. Schmidt, M. Taketo, G. Robinson, and R. Cardiff, Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors, Oncogene, vol.21, pp.5548-56, 2002.

E. Schmidt and A. Arnold, In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53, Transgenic Research, vol.10, issue.25, pp.471-479, 2001.

J. Krieken, P. Kluin, and E. Schuuring, Transgenic mice with mammary gland targeted CHAPITRE 2 : RÉSULTATS 96

K. Wa-g-ne-r, T. Wa-rd, B. Wiseman, R. Hennighausen, and L. , Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice, Transgenic Research, vol.10, pp.545-53, 2001.

C. Marcocci and C. Giani, Increased prevalence of primary hyperparathyroidism in treated breast cancer, J Endocrinol Invest, vol.24, pp.315-335, 2001.

R. Serra and M. Crowley, Mouse models of transforming growth factor ?? impact in breast development and cancer, Endocrine Related Cancer, vol.12, issue.4, pp.749-60, 2005.
DOI : 10.1677/erc.1.00936

P. Cowin, T. Rowlands, and S. Hatsell, Cadherins and catenins in breast cancer, Current Opinion in Cell Biology, vol.17, issue.5
DOI : 10.1016/j.ceb.2005.08.014

A. Imbert, R. Eelkema, S. Jordan, H. Feiner, and P. Cowin, ??n89??-Catenin Induces Precocious Development, Differentiation, and Neoplasia in Mammary Gland, The Journal of Cell Biology, vol.120, issue.3, pp.555-68, 2001.
DOI : 10.1074/jbc.272.40.25243

J. Michaelson and P. Leder, ??-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland, Oncogene, vol.20, issue.37, pp.5093-5102, 2001.
DOI : 10.1038/sj.onc.1204586

H. Taketo, M. Cardiff, R. Hennighausen, L. Khazaie, and K. , Activation of β-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias, Proceedings of the National Academy of Sciences of the United States of America, vol.99, pp.219-243, 2002.

T. Rowlands, I. Pechenkina, S. Hatsell, R. Pestell, and P. Cowin, Dissecting the roles of ??-catenin and cyclin D1 during mammary development and neoplasia, Proceedings of the National Academy of Sciences, vol.100, issue.20, pp.11400-11405, 2003.
DOI : 10.1073/pnas.1534601100

S. K. Agarwal, S. C. Guru, and C. Heppner, Menin Interacts with the AP1 Transcription Factor JunD and Represses JunD-Activated Transcription, Cell, vol.96, issue.1, pp.143-152, 1999.
DOI : 10.1016/S0092-8674(00)80967-8

S. K. Agarwal, S. Impey, and S. Mcweeney, Distribution of Menin-Occupied Regions in Chromatin Specifies a Broad Role of Menin in Transcriptional Regulation, Neoplasia, vol.9, issue.2, pp.101-107, 2007.
DOI : 10.1593/neo.06706

S. K. Agarwal, E. A. Novotny, and J. S. Crabtree, Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter, Proceedings of the National Academy of Sciences, vol.100, issue.19, pp.10770-10775, 2003.
DOI : 10.1073/pnas.1834524100

E. R. Andrechek, S. Mori, R. E. Rempel, J. T. Chang, and J. R. Nevins, Patterns of cell signaling pathway activation that characterize mammary development, Development, vol.135, issue.14, pp.2403-2413, 2008.
DOI : 10.1242/dev.019018

L. M. Arendt and L. A. Schuler, Transgenic Models to Study Actions of Prolactin in Mammary Neoplasia, Journal of Mammary Gland Biology and Neoplasia, vol.27, issue.Suppl 2, pp.29-40, 2008.
DOI : 10.1007/s10911-008-9073-9

A. Aziz, T. Miyake, K. A. Engleka, J. A. Epstein, and J. C. Mcdermott, Menin expression modulates mesenchymal cell commitment to the myogenic and osteogenic lineages, Developmental Biology, vol.332, issue.1, pp.116-130, 2009.
DOI : 10.1016/j.ydbio.2009.05.555

S. A. Backman, D. Ghazarian, and K. So, Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten, Proceedings of the National Academy of Sciences, vol.101, issue.6, pp.1725-1730, 2004.
DOI : 10.1073/pnas.0308217100

F. Bai, X. H. Pei, T. Nishikawa, M. D. Smith, and Y. Xiong, p18Ink4c, but Not p27Kip1, Collaborates with Men1 To Suppress Neuroendocrine Organ Tumors, Molecular and Cellular Biology, vol.27, issue.4, pp.1495-1504, 2007.
DOI : 10.1128/MCB.01764-06

F. Bai, X. H. Pei, P. P. Pandolfi, and Y. Xiong, p18Ink4c and Pten Constrain a Positive Regulatory Loop between Cell Growth and Cell Cycle Control, Molecular and Cellular Biology, vol.26, issue.12, pp.4564-4576, 2006.
DOI : 10.1128/MCB.00266-06

C. Bauters, L. Leclerc, J. L. Wémeau, C. Proye, P. Pigny et al., N??oplasies endocriniennes multiples. Quand et comment les rechercher??? Apports r??cents de la g??n??tique, La Revue de M??decine Interne, vol.24, issue.11, pp.721-729, 2003.
DOI : 10.1016/S0248-8663(03)00212-1

W. Bazzi, M. Renon, and C. Vercherat, MEN1 Missense Mutations Impair Sensitization to Apoptosis Induced by Wild-Type Menin in Endocrine Pancreatic Tumor Cells, Gastroenterology, vol.135, issue.5, 2008.
DOI : 10.1053/j.gastro.2008.07.031
URL : https://hal.archives-ouvertes.fr/hal-00391951

R. R. Behringer, M. J. Finegold, and R. L. Cate, M??llerian-inhibiting substance function during mammalian sexual development, Cell, vol.79, issue.3, pp.415-425, 1994.
DOI : 10.1016/0092-8674(94)90251-8

P. Bertolino, I. Radovanovic, H. Casse, A. Aguzzi, Z. Q. Wang et al., Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs, Mechanisms of Development, vol.120, issue.5, pp.549-560, 2003.
DOI : 10.1016/S0925-4773(03)00039-X

P. Bertolino, W. M. Tong, D. Galendo, Z. Q. Wang, and C. X. Zhang, Mutant Mice Develop a Range of Endocrine Tumors Mimicking Multiple Endocrine Neoplasia Type 1, Molecular Endocrinology, vol.17, issue.9, pp.1880-1892, 2003.
DOI : 10.1210/me.2003-0154

P. Bertolino, W. M. Tong, P. L. Herrera, H. Casse, C. X. Zhang et al., Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice, Z. Q. Cancer Res, vol.63, pp.4836-4841, 2003.

R. Bhatia-gaur, A. A. Donjacour, and P. J. Sciavolino, Roles for Nkx3.1 in prostate development and cancer, Genes & Development, vol.13, issue.8, pp.966-977, 1999.
DOI : 10.1101/gad.13.8.966

B. Bierie, M. Nozawa, and J. P. Renou, Activation of ??-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation, Oncogene, vol.22, issue.25, pp.3875-3887, 2003.
DOI : 10.1038/sj.onc.1206426

C. A. Biondi, M. G. Gartside, and P. Waring, Conditional Inactivation of the Men1 Gene Leads to Pancreatic and Pituitary Tumorigenesis but Does Not Affect Normal Development of These Tissues, Molecular and Cellular Biology, vol.24, issue.8, pp.3125-3131, 2004.
DOI : 10.1128/MCB.24.8.3125-3131.2004

J. Blando, M. Portis, and F. Benavides, PTEN Deficiency Is Fully Penetrant for Prostate Adenocarcinoma in C57BL/6 Mice via mTOR-Dependent Growth, The American Journal of Pathology, vol.174, issue.5, pp.1869-1879, 2009.
DOI : 10.2353/ajpath.2009.080055

R. Boni, A. O. Vortmeyer, and S. Pack, Somatic Mutations of the MEN1 Tumor Suppressor Gene Detected in Sporadic Angiofibromas, Journal of Investigative Dermatology, vol.111, issue.3, pp.539-540, 1998.
DOI : 10.1046/j.1523-1747.1998.00317.x

M. L. Brandi, R. F. Gagel, and A. Angeli, CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.12, pp.5658-5671, 2001.
DOI : 10.1210/jcem.86.12.8070

S. G. Brodie, X. Xu, W. Qiao, W. M. Li, L. Cao et al., Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice, Oncogene, vol.20, issue.51, pp.7514-7523, 2001.
DOI : 10.1038/sj.onc.1204929

J. R. Burgess, T. M. Greenaway, and J. J. Shepherd, Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1, Journal of Internal Medicine, vol.40, issue.6, pp.465-470, 1998.
DOI : 10.1001/archsurg.133.2.126

V. Busygina, K. Suphapeetiporn, L. R. Marek, R. S. Stowers, T. Xu et al., Hypermutability in a Drosophila model for multiple endocrine neoplasia type 1, Human Molecular Genetics, vol.13, issue.20, pp.2399-2408, 2004.
DOI : 10.1093/hmg/ddh271

K. M. Cadigan and R. Nusse, Wnt signaling: a common theme in animal??development, Genes & Development, vol.11, issue.24, pp.3286-3305, 1997.
DOI : 10.1101/gad.11.24.3286

Y. Cao, R. Liu, and X. Jiang, Nuclear-cytoplasmic shuttling of menin regulates nuclear translocation of {beta}-catenin, Mol. Cell. Biol, pp.335-00309, 2009.

R. D. Cardiff, M. R. Anver, and B. A. Gusterson, The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting???, Oncogene, vol.19, issue.8, pp.968-988, 2000.
DOI : 10.1038/sj.onc.1203277

S. C. Chandrasekharappa, S. C. Guru, and P. Manickam, Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1 , Science, vol.276, issue.5311, pp.404-407, 1997.
DOI : 10.1126/science.276.5311.404

S. C. Chandrasekharappa and B. T. Teh, Clinical and Molecular Aspects of Multiple Endocrine Neoplasia Type 1, Front Horm Res, vol.28, pp.50-80, 2001.
DOI : 10.1159/000061047

G. Chen, A. , J. Wang, and M. , Menin Promotes the Wnt Signaling Pathway in Pancreatic Endocrine Cells, Molecular Cancer Research, vol.6, pp.1894-1907, 2008.
DOI : 10.1158/1541-7786.MCR-07-2206

Y. X. Chen, J. Yan, and K. Keeshan, The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression, Proceedings of the National Academy of Sciences, vol.103, issue.4, pp.1018-1023, 2006.
DOI : 10.1073/pnas.0510347103

T. Cherlet and L. Murphy, Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors, Molecular and Cellular Biochemistry, vol.3, issue.1-2, pp.33-42, 2007.
DOI : 10.1007/s11010-007-9551-1

A. M. Cheung, A. Elia, and M. Tsao, Brca2 Deficiency Does Not Impair Mammary Epithelium Development but Promotes Mammary Adenocarcinoma Formation in p53+/- Mutant Mice, Cancer Research, vol.64, issue.6, pp.1959-1965, 2004.
DOI : 10.1158/0008-5472.CAN-03-2270

J. E. Chipuk, S. C. Cornelius, and N. J. Pultz, The Androgen Receptor Represses Transforming Growth Factor-?? Signaling through Interaction with Smad3, Journal of Biological Chemistry, vol.277, issue.2, pp.1240-1248, 2002.
DOI : 10.1074/jbc.M108855200

R. F. Chuaqui, Z. Zhuang, M. R. Emmert-buck, L. A. Liotta, and M. J. Merino, Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast, Am J Pathol, vol.150, pp.297-303, 1997.

S. C. Costa, L. S. Nascimento, F. J. Ferreira, P. S. Mattos, L. H. Camara-lopes et al., Lack of mutations of exon 2 of the MEN1 gene in endocrine and nonendocrine sporadic tumors, Brazilian Journal of Medical and Biological Research, vol.34, issue.7, pp.861-865, 2001.
DOI : 10.1590/S0100-879X2001000700004

P. Cowin, T. M. Rowlands, and S. J. Hatsell, Cadherins and catenins in breast cancer, Current Opinion in Cell Biology, vol.17, issue.5, pp.499-508, 2005.
DOI : 10.1016/j.ceb.2005.08.014

J. S. Crabtree, P. C. Scacheri, and J. M. Ward, A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors, Proceedings of the National Academy of Sciences, vol.98, issue.3, pp.1118-1123, 2001.
DOI : 10.1073/pnas.98.3.1118

J. S. Crabtree, P. C. Scacheri, and J. M. Ward, Of Mice and MEN1: Insulinomas in a Conditional Mouse Knockout, Molecular and Cellular Biology, vol.23, issue.17, pp.6075-6085, 2003.
DOI : 10.1128/MCB.23.17.6075-6085.2003

J. Damber and G. Aus, Prostate cancer. The Lancet, pp.1710-1721, 2008.

P. G. Dean, J. A. Van-heerden, and D. R. Farley, Are Patients with Multiple Endocrine Neoplasia Type I Prone to Premature Death?, World Journal of Surgery, vol.24, issue.11, pp.1437-1441, 2000.
DOI : 10.1007/s002680010237

P. W. Derksen, X. Liu, and F. Saridin, Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis, Cancer Cell, vol.10, issue.5, pp.437-449, 2006.
DOI : 10.1016/j.ccr.2006.09.013

D. Cristofano, A. De-acetis, M. Koff, A. Cordon-cardo, C. Pandolfi et al., Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse, Nature Genetics, vol.27, issue.2, pp.222-224, 2001.
DOI : 10.1038/84879

D. Sant-'agnese and P. A. , Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects, Urology, vol.51, pp.121-124, 1998.

G. M. Doherty, J. A. Olson, M. M. Frisella, T. C. Lairmore, S. A. Wells et al., Lethality of Multiple Endocrine Neoplasia Type I, World Journal of Surgery, vol.22, issue.6, pp.581-586, 1998.
DOI : 10.1007/s002689900438

L. A. Donehower, M. Harvey, and H. Vogel, Effects of genetic background on tumorigenesis inp53-deficient mice, Molecular Carcinogenesis, vol.68, issue.1, pp.16-22, 1995.
DOI : 10.1002/mc.2940140105

K. M. Dreijerink, K. W. Mulder, G. S. Winkler, J. W. Hoppener, C. J. Lips et al., Menin Links Estrogen Receptor Activation to Histone H3K4 Trimethylation, Cancer Research, vol.66, issue.9, pp.4929-4935, 2006.
DOI : 10.1158/0008-5472.CAN-05-4461

K. M. Dreijerink, R. A. Varier, and R. Van-nuland, Regulation of vitamin D receptor function in MEN1-related parathyroid adenomas, Molecular and Cellular Endocrinology, vol.313, issue.1-2, 2009.
DOI : 10.1016/j.mce.2009.08.020
URL : https://hal.archives-ouvertes.fr/hal-00522862

K. M. Dreijerink, R. A. Varier, and O. Van-beekum, The Multiple Endocrine Neoplasia type 1 (MEN1) tumor suppressor regulates PPAR{gamma}-dependent adipocyte differentiation, Mol. Cell. Biol, pp.1001-01008, 2009.

K. B. Ewan, H. A. Oketch-rabah, S. A. Ravani, G. Shyamala, H. L. Moses et al., Proliferation of Estrogen Receptor-??-Positive Mammary Epithelial Cells Is Restrained by Transforming Growth Factor-??1 in Adult Mice, The American Journal of Pathology, vol.167, issue.2, pp.409-417, 2005.
DOI : 10.1016/S0002-9440(10)62985-9

M. Farago, I. Dominguez, and E. Landesman-bollag, Kinase-Inactive Glycogen Synthase Kinase 3?? Promotes Wnt Signaling and Mammary Tumorigenesis, Cancer Research, vol.65, issue.13, pp.5792-5801, 2005.
DOI : 10.1158/0008-5472.CAN-05-1021

S. M. Farley, G. Chen, and S. Guo, Menin Localizes to Chromatin Through an ATR-CHK1 Mediated Pathway After UV-Induced DNA Damage, Journal of Surgical Research, vol.133, issue.1, pp.29-37, 2006.
DOI : 10.1016/j.jss.2006.02.021

P. Fierabracci, A. Pinchera, and P. Miccoli, Increased prevalence of primary hyperparathyroidism in treated breast cancer, Journal of Endocrinological Investigation, vol.95, issue.5, pp.315-320, 2001.
DOI : 10.1007/BF03343867

S. Fontaniere, H. Casse, P. Bertolino, and C. X. Zhang, Analysis of p27Kip1 Expression in Insulinomas Developed in Pancreatic ??-cell Specific Men1 Mutant Mice, Familial Cancer, vol.16, issue.3, pp.49-54, 2006.
DOI : 10.1007/s10689-005-2575-3

S. Fontaniere, B. Duvillie, R. Scharfmann, C. Carreira, Z. Q. Wang et al., Tumour suppressor menin is essential for development of the pancreatic endocrine cells, Journal of Endocrinology, vol.199, issue.2, pp.287-298, 2008.
DOI : 10.1677/JOE-08-0289

E. Forrester, A. Chytil, and B. Bierie, Effect of Conditional Knockout of the Type II TGF-?? Receptor Gene in Mammary Epithelia on Mammary Gland Development and Polyomavirus Middle T Antigen Induced Tumor Formation and Metastasis, Cancer Research, vol.65, issue.6, pp.2296-2302, 2005.
DOI : 10.1158/0008-5472.CAN-04-3272

D. S. Franklin, V. L. Godfrey, D. A. O-'brien, C. Deng, and Y. Xiong, Functional Collaboration between Different Cyclin-Dependent Kinase Inhibitors Suppresses Tumor Growth with Distinct Tissue Specificity, Molecular and Cellular Biology, vol.20, issue.16, pp.6147-6158, 2000.
DOI : 10.1128/MCB.20.16.6147-6158.2000

R. C. Gallagher, T. Hay, and V. Meniel, Inactivation of Apc perturbs mammary development, but only directly results in acanthoma in the context of Tcf-1 deficiency, Oncogene, vol.21, issue.42, pp.6446-6457, 2002.
DOI : 10.1038/sj.onc.1205892

A. Gallo, C. Cuozzo, and I. Esposito, Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation, Oncogene, vol.21, issue.42, pp.6434-6445, 2002.
DOI : 10.1038/sj.onc.1205822

H. Gao, X. Ouyang, and W. Banach-petrosky, A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis, Proceedings of the National Academy of Sciences, vol.101, issue.49, pp.17204-17209, 2004.
DOI : 10.1073/pnas.0407693101

C. Gaspar, P. Franken, and L. Molenaar, A Targeted Constitutive Mutation in the Apc Tumor Suppressor Gene Underlies Mammary But Not Intestinal Tumorigenesis, PLoS Genetics, vol.18, issue.7, 2009.
DOI : 10.1371/journal.pgen.1000547.t001

E. A. Geerdink, R. B. Van-der-luijt, and C. J. Lips, Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening?, European Journal of Endocrinology, vol.149, issue.6, pp.577-582, 2003.
DOI : 10.1530/eje.0.1490577

A. E. Gobl, M. Berg, J. R. Lopez-egido, K. Oberg, B. Skogseid et al., Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1447, issue.1, pp.51-56, 1999.
DOI : 10.1016/S0167-4781(99)00132-3

A. E. Gorska, R. A. Jensen, Y. Shyr, M. E. Aakre, N. A. Bhowmick et al., Transgenic Mice Expressing a Dominant-Negative Mutant Type II Transforming Growth Factor-?? Receptor Exhibit Impaired Mammary Development and Enhanced Mammary Tumor Formation, The American Journal of Pathology, vol.163, issue.4, pp.1539-1549, 2003.
DOI : 10.1016/S0002-9440(10)63510-9

F. Gounari, S. Signoretti, and R. T. Bronson, Stabilization of ??-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia, Oncogene, vol.21, issue.26, pp.4099-4107, 2002.
DOI : 10.1038/sj.onc.1205562

S. C. Guru, J. S. Crabtree, and K. D. Brown, Isolation, genomic organization, and expression analysis of Men1, the murine homolog of the MEN1 gene, Mammalian Genome, vol.10, issue.6, pp.592-596, 1999.
DOI : 10.1007/s003359901051

S. C. Guru, P. K. Goldsmith, and A. L. Burns, Menin, the product of the MEN1 gene, is a nuclear protein, Proceedings of the National Academy of Sciences, vol.95, issue.4, pp.1630-1634, 1998.
DOI : 10.1073/pnas.95.4.1630

M. Hashimoto, S. Kyo, and X. Hua, Role of menin in the regulation of telomerase activity in normal and cancer cells, Int J Oncol, vol.33, pp.333-340, 2008.

S. A. Hayes, M. Zarnegar, and M. Sharma, SMAD3 Represses Androgen Receptormediated Transcription, Cancer Res, vol.61, pp.2112-2118, 2001.

L. Hennighausen, G. W. Robinson, K. Wagner, and X. Liu, Prolactin Signaling in Mammary Gland Development, Journal of Biological Chemistry, vol.272, issue.12, pp.7567-7569, 1997.
DOI : 10.1074/jbc.272.12.7567

C. Heppner, K. Y. Bilimoria, and S. K. Agarwal, The tumor suppressor protein menin interacts with NF-??B proteins and inhibits NF-??B-mediated transactivation, Oncogene, vol.20, issue.36, pp.4917-4925, 2001.
DOI : 10.1038/sj.onc.1204529

O. Hessman, D. Lindberg, and A. Einarsson, Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors, Genes, Chromosomes and Cancer, vol.57, issue.3, pp.258-264, 1999.
DOI : 10.1002/(SICI)1098-2264(199911)26:3<258::AID-GCC11>3.0.CO;2-2

M. Hofmann, T. Schilling, and P. Heilmann, Multiple endocrine neoplasia type 1 associated with multiple lipomas, Medizinische Klinik, vol.35, issue.Suppl. 2, pp.546-549, 1998.
DOI : 10.1007/BF03042664

M. Honda, T. Tsukada, and T. Horiuchi, Primary Hyperparathyroidism Associatiated with Aldosterone-Producing Adrenocortical Adenoma and Breast Cancer: Relation to MEN1 Gene, Internal Medicine, vol.43, issue.4, pp.310-314, 2004.
DOI : 10.2169/internalmedicine.43.310

Y. Hosokawa, A. Papanikolaou, and R. D. Cardiff, In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53, Transgenic Research, vol.10, issue.5, pp.471-478, 2001.
DOI : 10.1023/A:1012064911751

C. M. Hughes, O. Rozenblatt-rosen, and T. A. Milne, Menin Associates with a Trithorax Family Histone Methyltransferase Complex and with the Hoxc8 Locus, Molecular Cell, vol.13, issue.4, pp.587-597, 2004.
DOI : 10.1016/S1097-2765(04)00081-4

N. Hussein, H. Casse, and S. Fontaniere, Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis, European Journal of Cancer, vol.43, issue.2, pp.402-414, 2007.
DOI : 10.1016/j.ejca.2006.08.038

N. Hussein, J. Lu, and H. Casse, Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-?? pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice, Endocrine Related Cancer, vol.15, issue.1, pp.217-227, 2008.
DOI : 10.1677/ERC-06-0046
URL : https://hal.archives-ouvertes.fr/hal-00671020

Y. Ikeo, A. Sakurai, and R. Suzuki, Proliferation-Associated Expression of the MEN1 Gene as Revealed by In Situ Hybridization: Possible Role of the Menin as a Negative Regulator of Cell Proliferation Under DNA Damage, Laboratory Investigation, vol.135, issue.6, pp.797-804, 2000.
DOI : 10.1016/0165-4608(95)98126-J

Y. Ikeo, W. Yumita, A. Sakurai, and K. Hashizume, JunD-Menin Interaction Regulates c-Jun-mediated AP-1 Transactivation, Endocrine Journal, vol.51, issue.3, pp.333-342, 2004.
DOI : 10.1507/endocrj.51.333

A. Imbert, R. Eelkema, S. Jordan, H. Feiner, and P. Cowin, ??n89??-Catenin Induces Precocious Development, Differentiation, and Neoplasia in Mammary Gland, The Journal of Cell Biology, vol.120, issue.3, pp.555-568, 2001.
DOI : 10.1074/jbc.272.40.25243

K. Ishii, K. Imanaka-yoshida, T. Yoshida, and Y. Sugimura, Role of stromal tenascin-C in mouse prostatic development and epithelial cell differentiation, Developmental Biology, vol.324, issue.2, pp.310-319, 2008.
DOI : 10.1016/j.ydbio.2008.09.029

T. Jacks, L. Remington, and B. O. Williams, Tumor spectrum analysis in p53-mutant mice, Current Biology, vol.4, issue.1, pp.1-7, 1994.
DOI : 10.1016/S0960-9822(00)00002-6

D. J. Jerry, F. S. Kittrell, and C. Kuperwasser, A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development, Oncogene, vol.19, issue.8, pp.1052-1058, 2000.
DOI : 10.1038/sj.onc.1203270

S. Jin, H. Mao, and R. W. Schnepp, Menin associates with FANCD2, a protein involved in repair of DNA damage, Cancer Res, vol.63, pp.4204-4210, 2003.

J. Jonkers, R. Meuwissen, H. Van-der-gulden, H. Peterse, M. Van-der-valk et al., Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer, Nature Genetics, vol.29, issue.4, pp.418-425, 2001.
DOI : 10.1038/ng747

H. Kaji, L. Canaff, D. Goltzman, and G. N. Hendy, Cell cycle regulation of menin expression, Cancer Res, vol.59, pp.5097-5101, 1999.

H. Kaji, L. Canaff, J. J. Lebrun, D. Goltzman, and G. N. Hendy, Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type ?? signaling, Proceedings of the National Academy of Sciences, vol.98, issue.7, pp.3837-3842, 2001.
DOI : 10.1073/pnas.061358098

H. Kang, K. Huang, S. Y. Chang, W. Ma, W. Lin et al., Differential Modulation of Androgen Receptor-mediated Transactivation by Smad3 and Tumor Suppressor Smad4, Journal of Biological Chemistry, vol.277, issue.46, pp.43749-43756, 2002.
DOI : 10.1074/jbc.M205603200

S. K. Karnik, H. Chen, and G. W. Mclean, Menin Controls Growth of Pancreatic ??-Cells in Pregnant Mice and Promotes Gestational Diabetes Mellitus, Science, vol.318, issue.5851, pp.806-809, 2007.
DOI : 10.1126/science.1146812

S. K. Karnik, C. M. Hughes, and X. Gu, Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c, Proceedings of the National Academy of Sciences, vol.102, issue.41, pp.14659-14664, 2005.
DOI : 10.1073/pnas.0503484102

H. Kim, J. E. Lee, E. J. Cho, J. O. Liu, and H. D. Youn, Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A- histone deacetylase complex, Cancer Res, vol.63, pp.6135-6139, 2003.

M. J. Kim, R. D. Cardiff, and N. Desai, Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis, Proceedings of the National Academy of Sciences of the United States of America, pp.2884-2889, 2002.
DOI : 10.1073/pnas.042688999

Y. S. Kim, A. L. Burns, and P. K. Goldsmith, Stable overexpression of MEN1 suppresses tumorigenicity of RAS, Oncogene, vol.18, issue.43, pp.5936-5942, 1999.
DOI : 10.1038/sj.onc.1203005

M. C. Kottemann and A. E. Bale, Characterization of DNA damage-dependent cell cycle checkpoints in a menin-deficient model, DNA Repair, vol.8, issue.8, pp.944-952, 2009.
DOI : 10.1016/j.dnarep.2009.06.001

C. Kuperwasser, G. D. Hurlbut, and F. S. Kittrell, Development of Spontaneous Mammary Tumors in BALB/c p53 Heterozygous Mice, The American Journal of Pathology, vol.157, issue.6, pp.2151-2159, 2000.
DOI : 10.1016/S0002-9440(10)64853-5

M. Kuraguchi, N. Y. Ohene-baah, D. Sonkin, R. T. Bronson, and R. Kucherlapati, Genetic Mechanisms in Apc-Mediated Mammary Tumorigenesis, PLoS Genetics, vol.4, issue.2, 2009.
DOI : 10.1371/journal.pgen.1000367.s010

P. La, A. Desmond, Z. Hou, A. C. Silva, R. W. Schnepp et al., Tumor suppressor menin: the essential role of nuclear localization signal domains in coordinating gene expression, Oncogene, vol.114, issue.25, pp.3537-3546, 2006.
DOI : 10.1038/sj.onc.1209400

P. La, A. C. Silva, and Z. Hou, Direct Binding of DNA by Tumor Suppressor Menin, Journal of Biological Chemistry, vol.279, issue.47, pp.49045-49054, 2004.
DOI : 10.1074/jbc.M409358200

P. La, Y. Yang, and S. K. Karnik, Menin-mediated Caspase 8 Expression in Suppressing Multiple Endocrine Neoplasia Type 1, Journal of Biological Chemistry, vol.282, issue.43, pp.31332-31340, 2007.
DOI : 10.1074/jbc.M609555200

A. Lacerte, E. H. Lee, and R. Reynaud, Activin Inhibits Pituitary Prolactin Expression and Cell Growth through Smads, Pit-1 and Menin, Molecular Endocrinology, vol.18, issue.6, pp.1558-1569, 2004.
DOI : 10.1210/me.2003-0470

E. Landesman-bollag, R. Romieu-mourez, D. H. Song, G. E. Sonenshein, R. D. Cardiff et al., Protein kinase CK2 in mammary gland tumorigenesis, Oncogene, vol.20, issue.25, pp.3247-3257, 2001.
DOI : 10.1038/sj.onc.1204411

T. F. Lane and P. Leder, Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice, Oncogene, vol.15, issue.18, pp.2133-2144, 1997.
DOI : 10.1038/sj.onc.1201593

E. Latres, M. Malumbres, and R. Sotillo, Limited overlapping roles of P15INK4b and P18INK4c cell cycle inhibitors in proliferation and tumorigenesis, The EMBO Journal, vol.19, issue.13, pp.3496-3506, 2000.
DOI : 10.1093/emboj/19.13.3496

F. S. Lee, T. F. Lane, A. Kuo, G. M. Shackleford, and P. Leder, Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice., Proceedings of the National Academy of Sciences, vol.92, issue.6, pp.2268-2272, 1995.
DOI : 10.1073/pnas.92.6.2268

M. C. Lemos, B. Harding, S. M. Shalet, and R. V. Thakker, A novel MEN1 intronic mutation associated with multiple endocrine neoplasia type 1, Clinical Endocrinology, vol.42, issue.5, pp.709-713, 2007.
DOI : 10.1210/en.2004-0865

G. Li, G. W. Robinson, and R. Lesche, Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland, Development, vol.129, pp.4159-4170, 2002.

W. Li, W. Qiao, and L. Chen, Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice, Development, vol.130, issue.24, pp.6143-6153, 2003.
DOI : 10.1242/dev.00820

S. K. Libutti, J. S. Crabtree, and D. Lorang, Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism, Cancer Res, vol.63, pp.8022-8028, 2003.

S. J. Lin, K. Lee, and A. Y. Nikitin, Somatic Mutation of p53 Leads to Estrogen Receptor ??-Positive and -Negative Mouse Mammary Tumors with High Frequency of Metastasis, Cancer Research, vol.64, issue.10, pp.3525-3532, 2004.
DOI : 10.1158/0008-5472.CAN-03-3524

S. Y. Lin and S. J. Elledge, Multiple Tumor Suppressor Pathways Negatively Regulate Telomerase, Cell, vol.113, issue.7, pp.881-889, 2003.
DOI : 10.1016/S0092-8674(03)00430-6
URL : http://doi.org/10.1016/s0092-8674(03)00430-6

I. V. Litvinov, A. M. De-marzo, and J. T. Isaacs, Is the Achilles??? Heel for Prostate Cancer Therapy a Gain of Function in Androgen Receptor Signaling?, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.7, pp.2972-2982, 2003.
DOI : 10.1210/jc.2002-022038

X. Liu, H. Holstege, and H. Van-der-gulden, Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer, Proceedings of the National Academy of Sciences, vol.104, issue.29, pp.12111-12116, 2007.
DOI : 10.1073/pnas.0702969104

Y. Liu, J. Q. Mo, and Q. Hu, Targeted Overexpression of Vav3 Oncogene in Prostatic Epithelium Induces Nonbacterial Prostatitis and Prostate Cancer, Cancer Research, vol.68, issue.15, pp.6396-6406, 2008.
DOI : 10.1158/0008-5472.CAN-08-0645

K. A. Loffler, C. A. Biondi, and M. Gartside, Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1, International Journal of Cancer, vol.86, issue.2, pp.259-267, 2007.
DOI : 10.1002/ijc.22288

I. A. Lubensky, L. V. Debelenko, and Z. Zhuang, Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients, Cancer Res, vol.56, pp.5272-5278, 1996.

T. Ludwig, P. Fisher, S. Ganesan, and A. Efstratiadis, Tumorigenesis in mice carrying a truncating Brca1 mutation, Genes & Development, vol.15, issue.10, pp.1188-1193, 2001.
DOI : 10.1101/gad.879201

T. Ludwig, P. Fisher, V. Murty, and A. Efstratiadis, Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice, Oncogene, vol.20, issue.30, pp.3937-3948, 2001.
DOI : 10.1038/sj.onc.1204512

E. Macri and M. Loda, Role of p27 in prostate carcinogenesis, Cancer and Metastasis Reviews, vol.17, issue.4, pp.337-344, 1998.
DOI : 10.1023/A:1006133620914

I. Maillard, Y. Chen, and A. Friedman, Menin regulates the function of hematopoietic stem cells and lymphoid progenitors, Blood, vol.113, issue.8, pp.1661-1669, 2009.
DOI : 10.1182/blood-2008-01-135012

P. K. Majumder, C. Grisanzio, and F. O-'connell, A Prostatic Intraepithelial Neoplasia-Dependent p27Kip1 Checkpoint Induces Senescence and Inhibits Cell Proliferation and Cancer Progression, Cancer Cell, vol.14, issue.2, pp.146-155, 2008.
DOI : 10.1016/j.ccr.2008.06.002

P. K. Majumder, J. J. Yeh, and D. J. George, Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model, Proceedings of the National Academy of Sciences of the United States of America, pp.7841-7846, 2003.
DOI : 10.1073/pnas.1232229100

D. Malek, R. Gust, and B. Kleuser, 17-??-estradiol inhibits transforming-growth-factor-??-induced MCF-7 cell migration by Smad3-repression, European Journal of Pharmacology, vol.534, issue.1-3, pp.39-47, 2006.
DOI : 10.1016/j.ejphar.2006.01.025

L. R. Marek, M. C. Kottemann, P. M. Glazer, and A. E. Bale, MEN1 and FANCD2 mediate distinct mechanisms of DNA crosslink repair, DNA Repair, vol.7, issue.3, pp.476-486, 2008.
DOI : 10.1016/j.dnarep.2007.12.009

F. Marini, A. Falchetti, and F. Del-monte, Multiple endocrine neoplasia type 1, Orphanet Journal of Rare Diseases, vol.1, issue.1, p.38, 2006.
DOI : 10.1186/1750-1172-1-38

J. Massagué, TGFbeta in Cancer, pp.215-230, 2008.

J. Massagué, J. Seoane, and D. Wotton, Smad transcription factors, Genes & Development, vol.19, issue.23, pp.2783-2810, 2005.
DOI : 10.1101/gad.1350705

M. M. Matzuk, M. J. Finegold, Y. Mishina, A. Bradley, and R. R. Behringer, Synergistic effects of inhibins and mullerian-inhibiting substance on testicular tumorigenesis, Mol Endocrinol, vol.9, pp.1337-1345, 1995.

A. Mccarthy, C. J. Lord, and K. Savage, Conditional deletion of the <I>Lkb1</I> gene in the mouse mammary gland induces tumour formation, The Journal of Pathology, vol.9999, 2009.

A. Mccarthy, K. Savage, A. Gabriel, C. Naceur, J. S. Reis-filho et al., A mouse model of basal-like breast carcinoma with metaplastic elements, The Journal of Pathology, vol.20, issue.4, pp.389-398, 2007.
DOI : 10.1002/path.2124

H. Mehenni, N. Lin-marq, and K. Buchet-poyau, LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes, Human Molecular Genetics, vol.14, issue.15, pp.2209-2219, 2005.
DOI : 10.1093/hmg/ddi225

E. Mensah-osman, Y. Zavros, and J. L. Merchant, Somatostatin stimulates menin gene expression by inhibiting protein kinase A, AJP: Gastrointestinal and Liver Physiology, vol.295, issue.4, pp.843-854, 2008.
DOI : 10.1152/ajpgi.00607.2007

J. S. Michaelson and P. Leder, ??-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland, Oncogene, vol.20, issue.37, pp.5093-5099, 2001.
DOI : 10.1038/sj.onc.1204586

T. A. Milne, C. M. Hughes, and R. Lloyd, Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors, Proceedings of the National Academy of Sciences, vol.102, issue.3, pp.749-754, 2005.
DOI : 10.1073/pnas.0408836102

Y. Mishina, R. Rey, and M. J. Finegold, Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation., Genes & Development, vol.10, issue.20, pp.2577-2587, 1996.
DOI : 10.1101/gad.10.20.2577

K. Miyoshi, A. Rosner, and M. Nozawa, Activation of different Wnt/??-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors, Oncogene, vol.21, issue.36, pp.5548-5556, 2002.
DOI : 10.1038/sj.onc.1205686

K. Miyoshi, J. M. Shillingford, L. Provost, and F. , Activation of ??-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias, Proceedings of the National Academy of Sciences of the United States of America, pp.219-224, 2002.
DOI : 10.1073/pnas.012414099

J. Naito, H. Kaji, H. Sowa, G. N. Hendy, T. Sugimoto et al., Menin Suppresses Osteoblast Differentiation by Antagonizing the AP-1 Factor, JunD, Journal of Biological Chemistry, vol.280, issue.6, pp.4785-4791, 2005.
DOI : 10.1074/jbc.M408143200

J. Naito, H. Kaji, and H. Sowa, Expression and Functional Analysis of Menin in a Multiple Endocrine Neoplasia Type 1 (MEN1) Patient with Somatic Loss of Heterozygosity in Chromosome 11q13 and Unidentified Germline Mutation of the MEN1 Gene, Endocrine, vol.29, issue.3, pp.485-490, 2006.
DOI : 10.1385/ENDO:29:3:485

H. Namihira, M. Sato, and K. Murao, The multiple endocrine neoplasia type 1 gene product, menin, inhibits the human prolactin promoter activity, Journal of Molecular Endocrinology, vol.29, issue.3, pp.297-304, 2002.
DOI : 10.1677/jme.0.0290297

S. A. Narod and W. D. Foulkes, BRCA1 and BRCA2: 1994 and beyond, Nature Reviews Cancer, vol.14, issue.9, pp.665-676, 2004.
DOI : 10.1002/1521-1878(200008)22:8<728::AID-BIES6>3.3.CO;2-2

I. Nilsson, J. Zedenius, L. Yin, and A. Ekbom, The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy, Endocrine Related Cancer, vol.14, issue.1, pp.135-140, 2007.
DOI : 10.1677/erc.1.01261

N. Ohkura, M. Kishi, T. Tsukada, and K. Yamaguchi, Menin, a Gene Product Responsible for Multiple Endocrine Neoplasia Type 1, Interacts with the Putative Tumor Metastasis Suppressor nm23, Biochemical and Biophysical Research Communications, vol.282, issue.5, pp.1206-1210, 2001.
DOI : 10.1006/bbrc.2001.4723

O. I. Olopade, T. A. Grushko, R. Nanda, and D. Huo, Advances in Breast Cancer: Pathways to Personalized Medicine, Clinical Cancer Research, vol.14, issue.24, pp.7988-7999, 2008.
DOI : 10.1158/1078-0432.CCR-08-1211

S. K. Pal, K. Blazer, J. Weitzel, and G. Somlo, An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literature, Breast Cancer Research and Treatment, vol.6, issue.5, 2008.
DOI : 10.1007/s10549-008-0056-8

H. B. Pearson, A. Mccarthy, C. M. Collins, A. Ashworth, and A. R. Clarke, Lkb1 Deficiency Causes Prostate Neoplasia in the Mouse, Cancer Research, vol.68, issue.7, pp.2223-2232, 2008.
DOI : 10.1158/0008-5472.CAN-07-5169

X. Pei, F. Bai, and M. D. Smith, CDK Inhibitor p18INK4c Is a Downstream Target of GATA3 and Restrains Mammary Luminal Progenitor Cell Proliferation and Tumorigenesis, Cancer Cell, vol.15, issue.5, pp.389-401, 2009.
DOI : 10.1016/j.ccr.2009.03.004

X. H. Pei, F. Bai, M. D. Smith, and Y. Xiong, p18Ink4c Collaborates with Men1 to Constrain Lung Stem Cell Expansion and Suppress Non-Small-Cell Lung Cancers, Cancer Research, vol.67, issue.7, pp.3162-3170, 2007.
DOI : 10.1158/0008-5472.CAN-06-4517

G. Piecha, J. Chudek, and A. Wiecek, Multiple endocrine neoplasia type 1, European Journal of Internal Medicine, vol.19, issue.2, pp.99-103, 2008.
DOI : 10.1016/j.ejim.2007.08.004

C. Ratineau, C. Bernard, and G. Poncet, Reduction of Menin Expression Enhances Cell Proliferation and Is Tumorigenic in Intestinal Epithelial Cells, Journal of Biological Chemistry, vol.279, issue.23, pp.24477-24484, 2004.
DOI : 10.1074/jbc.M401835200

C. K. Ratnacaram, M. Teletin, M. Jiang, X. Meng, P. Chambon et al., Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma, Proceedings of the National Academy of Sciences, vol.105, issue.7, pp.2521-2526, 2008.
DOI : 10.1073/pnas.0712021105
URL : https://hal.archives-ouvertes.fr/hal-00282559

O. Renner, C. Blanco-aparicio, M. Grassow, M. Cañamero, J. F. Leal et al., Activation of Phosphatidylinositol 3-Kinase by Membrane Localization of p110?? Predisposes Mammary Glands to Neoplastic Transformation, Cancer Research, vol.68, issue.23, pp.9643-9653, 2008.
DOI : 10.1158/0008-5472.CAN-08-1539

M. M. Richert, K. L. Schwertfeger, J. W. Ryder, and S. M. Anderson, An atlas of mouse mammary gland development, Journal of Mammary Gland Biology and Neoplasia, vol.5, issue.2, pp.227-241, 2000.
DOI : 10.1023/A:1026499523505

T. M. Rowlands, I. V. Pechenkina, S. J. Hatsell, R. G. Pestell, and P. Cowin, Dissecting the roles of ??-catenin and cyclin D1 during mammary development and neoplasia, Proceedings of the National Academy of Sciences of the United States of America, pp.11400-11405, 2003.
DOI : 10.1073/pnas.1534601100

Y. Sayo, K. Murao, and H. Imachi, The Multiple Endocrine Neoplasia Type 1 Gene Product, Menin, Inhibits Insulin Production in Rat Insulinoma Cells, Endocrinology, vol.143, issue.6, pp.2437-2440, 2002.
DOI : 10.1210/endo.143.6.8950

P. C. Scacheri, J. S. Crabtree, and A. L. Kennedy, Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1, Mammalian Genome, vol.57, issue.11, pp.872-877, 2004.
DOI : 10.1007/s00335-004-2395-z

P. C. Scacheri, S. Davis, and D. T. Odom, Genome-Wide Analysis of Menin Binding Provides Insights into MEN1 Tumorigenesis, PLoS Genetics, vol.31, issue.4, p.51, 2006.
DOI : 10.1371/journal.pgen.0020051.sg001

R. W. Schnepp, Y. X. Chen, and H. Wang, Mutation of Tumor Suppressor Gene Men1 Acutely Enhances Proliferation of Pancreatic Islet Cells, Cancer Research, vol.66, issue.11, pp.5707-5715, 2006.
DOI : 10.1158/0008-5472.CAN-05-4518

R. W. Schnepp, Z. Hou, and H. Wang, Functional Interaction between Tumor Suppressor Menin and Activator of S-Phase Kinase, Cancer Research, vol.64, issue.18, pp.6791-6796, 2004.
DOI : 10.1158/0008-5472.CAN-04-0724

R. W. Schnepp, H. Mao, and S. M. Sykes, Menin Induces Apoptosis in Murine Embryonic Fibroblasts, Journal of Biological Chemistry, vol.279, issue.11, pp.10685-10691, 2004.
DOI : 10.1074/jbc.M308073200

R. Serra and M. R. Crowley, Mouse models of transforming growth factor ?? impact in breast development and cancer, Endocrine Related Cancer, vol.12, issue.4, pp.749-760, 2005.
DOI : 10.1677/erc.1.00936

S. B. Shappell, G. V. Thomas, and R. L. Roberts, Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee, Cancer Research, vol.64, issue.6, pp.2270-2305, 2004.
DOI : 10.1158/0008-5472.CAN-03-0946

C. J. Sherr and J. M. Roberts, CDK inhibitors: positive and negative regulators of G1-phase progression, Genes & Development, vol.13, issue.12, pp.1501-1512, 1999.
DOI : 10.1101/gad.13.12.1501

H. Sowa, H. Kaji, and L. Canaff, Inactivation of Menin, the Product of the Multiple Endocrine Neoplasia Type 1 Gene, Inhibits the Commitment of Multipotential Mesenchymal Stem Cells into the Osteoblast Lineage, Journal of Biological Chemistry, vol.278, issue.23, pp.21058-21069, 2003.
DOI : 10.1074/jbc.M302044200

H. Sowa, H. Kaji, and G. N. Hendy, Menin Is Required for Bone Morphogenetic Protein 2- and Transforming Growth Factor ??-regulated Osteoblastic Differentiation through Interaction with Smads and Runx2, Journal of Biological Chemistry, vol.279, issue.39, pp.40267-40275, 2004.
DOI : 10.1074/jbc.M401312200

H. Sowa, H. Kaji, and R. Kitazawa, Menin Inactivation Leads to Loss of Transforming Growth Factor ?? Inhibition of Parathyroid Cell Proliferation and Parathyroid Hormone Secretion, Cancer Research, vol.64, issue.6, pp.2222-2228, 2004.
DOI : 10.1158/0008-5472.CAN-03-3334

P. Stalberg, P. Grimfjard, and M. Santesson, Transfection of the Multiple Endocrine Neoplasia Type 1 Gene to a Human Endocrine Pancreatic Tumor Cell Line Inhibits Cell Growth and Affects Expression of JunD, ??-Like Protein 1/Preadipocyte Factor-1, Proliferating Cell Nuclear Antigen, and QM/Jif-1, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.5, pp.2326-2337, 2004.
DOI : 10.1210/jc.2003-031228

V. Stambolic, M. Tsao, D. Macpherson, A. Suzuki, W. B. Chapman et al., High Incidence of Breast and Endometrial Neoplasia Resembling Human Cowden Syndrome in pten+/-Mice, Cancer Res, vol.60, pp.3605-3611, 2000.

C. Stewart, F. Parente, and F. Piehl, Characterization of the mouse Men1 gene and its expression during development, Oncogene, vol.17, issue.19, pp.2485-2493, 1998.
DOI : 10.1038/sj.onc.1202164

K. E. Sukhodolets, A. B. Hickman, and S. K. Agarwal, The 32-Kilodalton Subunit of Replication Protein A Interacts with Menin, the Product of the MEN1 Tumor Suppressor Gene, Molecular and Cellular Biology, vol.23, issue.2, pp.493-509, 2003.
DOI : 10.1128/MCB.23.2.493-509.2003

J. Svensson, J. Kindblom, and R. Shao, Liver-derived IGF1 enhances the androgenic response in prostate, Journal of Endocrinology, vol.199, issue.3, pp.489-497, 2008.
DOI : 10.1677/JOE-08-0406

S. H. Tan and M. T. Nevalainen, Signal transducer and activator of transcription 5A/B in prostate and breast cancers, Endocrine Related Cancer, vol.15, issue.2, pp.367-390, 2008.
DOI : 10.1677/ERC-08-0013

B. Teissedre, A. Pinderhughes, A. Incassati, S. J. Hatsell, M. Hiremath et al., MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors, PLoS ONE, vol.4, 2009.

R. V. Thakker, Multiple endocrine neoplasia--syndromes of the twentieth century, J Clin Endocrinol Metab, vol.83, pp.2617-2620, 1998.

A. Theillaumas, M. Blanc, and C. Couderc, Relation between menin expression and NF-??B activity in an intestinal cell line, Molecular and Cellular Endocrinology, vol.291, issue.1-2, pp.109-115, 2008.
DOI : 10.1016/j.mce.2008.05.019

G. Thomas, K. B. Jacobs, and M. Yeager, Multiple loci identified in a genome-wide association study of prostate cancer, Nature Genetics, vol.95, issue.3, pp.310-315, 2008.
DOI : 10.1210/jc.86.4.1801

P. Tomassetti, G. Cometa, D. Vecchio, and E. , Chromosomal instability in multiple endocrine neoplasia type 1 cytogenetic evaluation with DEB test, Cancer Genetics and Cytogenetics, vol.79, issue.2, pp.123-126, 1995.
DOI : 10.1016/0165-4608(95)98126-J

L. C. Trotman, M. Niki, and Z. A. Dotan, Pten Dose Dictates Cancer Progression in the Prostate, PLoS Biology, vol.101, issue.3, p.59, 2003.
DOI : 10.1371/journal.pbio.0000059.g006

A. S. Tsukamoto, R. Grosschedl, R. C. Guzman, T. Parslow, and H. E. Varmus, Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice, Cell, vol.55, issue.4, pp.619-625, 1988.
DOI : 10.1016/0092-8674(88)90220-6

T. Tsurusaki, D. Aoki, and H. Kanetake, Zone-Dependent Expression of Estrogen Receptors ?? and ?? in Human Benign Prostatic Hyperplasia, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.3, pp.1333-1340, 2003.
DOI : 10.1210/jc.2002-021015

D. Vageli, Z. Daniil, and J. Dahabreh, Microsatellite instability and loss of heterozygosity at the MEN1 locus in lung carcinoid tumors: A novel approach using real-time PCR with melting curve analysis in histopathologic material, Oncology Reports, vol.15, pp.557-564, 2006.
DOI : 10.3892/or.15.3.557

A. G. Van-rossum, M. P. Van-bragt, and E. Schuuring-scholtes, Transgenic mice with mammary gland targeted expression of human cortactin do not develop (premalignant ) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice, BMC Cancer, vol.6, 2006.

B. Verges, F. Boureille, and P. Goudet, Pituitary Disease in MEN Type 1 (MEN1): Data from the France-Belgium MEN1 Multicenter Study, Journal of Clinical Endocrinology & Metabolism, vol.87, issue.2, pp.457-465, 2002.
DOI : 10.1210/jc.87.2.457

O. Vierimaa, T. M. Ebeling, and S. Kytola, Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation, European Journal of Endocrinology, vol.157, issue.3, pp.285-294, 2007.
DOI : 10.1530/EJE-07-0195

K. Wagner, T. Ward, B. Davis, R. Wiseman, and L. Hennighausen, Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice, Transgenic Research, vol.10, issue.6, pp.545-553, 2001.
DOI : 10.1023/A:1013063514007

K. U. Wagner, R. J. Wall, and L. St-onge, Cre-mediated gene deletion in the mammary gland, Nucleic Acids Research, vol.25, issue.21, pp.4323-4330, 1997.
DOI : 10.1093/nar/25.21.4323

S. Wang, J. Gao, and Q. Lei, Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer, Cancer Cell, vol.4, issue.3, pp.209-221, 2003.
DOI : 10.1016/S1535-6108(03)00215-0

T. C. Wang, R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold et al., Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice, Nature, vol.369, issue.6482, pp.669-671, 1994.
DOI : 10.1038/369669a0

V. Wautot, S. Khodaei, and L. Frappart, Expression analysis of endogenous menin, the product of the multiple endocrine neoplasia type 1 gene, in cell lines and human tissues, International Journal of Cancer, vol.16, issue.6, pp.877-881, 2000.
DOI : 10.1002/(SICI)1097-0215(20000315)85:6<877::AID-IJC23>3.0.CO;2-F

V. Wautot, C. Vercherat, and J. Lespinasse, in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein, Human Mutation, vol.85, issue.1, pp.35-47, 2002.
DOI : 10.1002/humu.10092

M. H. Weinstein, S. Signoretti, and M. Loda, Diagnostic Utility of Immunohistochemical Staining for p63, a Sensitive Marker of Prostatic Basal Cells, Modern Pathology, vol.15, issue.12, pp.1302-1308, 2002.
DOI : 10.1097/01.MP.0000038460.95912.6E

L. Wu, Y. Wu, and B. Gathings, Smad4 as a Transcription Corepressor for Estrogen Receptor ??, Journal of Biological Chemistry, vol.278, issue.17, pp.15192-15200, 2003.
DOI : 10.1074/jbc.M212332200

H. Yaguchi, N. Ohkura, M. Takahashi, Y. Nagamura, I. Kitabayashi et al., Menin Missense Mutants Associated with Multiple Endocrine Neoplasia Type 1 Are Rapidly Degraded via the Ubiquitin-Proteasome Pathway, Molecular and Cellular Biology, vol.24, issue.15, pp.6569-6580, 2004.
DOI : 10.1128/MCB.24.15.6569-6580.2004

H. Yaguchi, N. Ohkura, T. Tsukada, and K. Yamaguchi, Menin, the Multiple Endocrine Neoplasia Type 1 Gene Product, Exhibits GTP-hydrolyzing Activity in the Presence of the Tumor Metastasis Suppressor nm23, Journal of Biological Chemistry, vol.277, issue.41, pp.38197-38204, 2002.
DOI : 10.1074/jbc.M204132200

J. Yan, Y. Yang, and H. Zhang, Menin interacts with IQGAP1 to enhance intercellular adhesion of ??-cells, Oncogene, vol.123, issue.7, pp.973-982, 2009.
DOI : 10.1038/onc.2008.435

Y. Yang and X. Hua, In search of tumor suppressing functions of menin, Molecular and Cellular Endocrinology, vol.265, issue.266, pp.265-266, 2007.
DOI : 10.1016/j.mce.2006.12.032

A. Yokoyama and M. L. Cleary, Menin Critically Links MLL Proteins with LEDGF on Cancer-Associated Target Genes, Cancer Cell, vol.14, issue.1, pp.36-46, 2008.
DOI : 10.1016/j.ccr.2008.05.003

A. Yokoyama, T. C. Somervaille, K. S. Smith, O. Rozenblatt-rosen, M. Meyerson et al., The Menin Tumor Suppressor Protein Is an Essential Oncogenic Cofactor for MLL-Associated Leukemogenesis, Cell, vol.123, issue.2, pp.207-218, 2005.
DOI : 10.1016/j.cell.2005.09.025

A. Yokoyama, Z. Wang, and J. Wysocka, Leukemia Proto-Oncoprotein MLL Forms a SET1-Like Histone Methyltransferase Complex with Menin To Regulate Hox Gene Expression, Molecular and Cellular Biology, vol.24, issue.13, pp.5639-5649, 2004.
DOI : 10.1128/MCB.24.13.5639-5649.2004

C. Zhong, G. Saribekyan, C. Liao, M. B. Cohen, and P. Roy-burman, Cooperation between FGF8b Overexpression and PTEN Deficiency in Prostate Tumorigenesis, Cancer Research, vol.66, issue.4, pp.2188-2194, 2006.
DOI : 10.1158/0008-5472.CAN-05-3440